BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8389690)

  • 1. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.
    Miyamoto Y; Takemori AE
    Drug Alcohol Depend; 1993 Apr; 32(2):163-7. PubMed ID: 8389690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Kamei J; Ohsawa M
    Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
    Miyamoto Y; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1141-5. PubMed ID: 8383738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propranolol on antinociceptive and withdrawal characteristics of morphine.
    Chipkin RE; Dewey WL; Harris LS; Lowenthal W
    Pharmacol Biochem Behav; 1975; 3(5):843-7. PubMed ID: 1800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats.
    Han JS; Zhang RL
    Drug Alcohol Depend; 1993 Jan; 31(2):169-75. PubMed ID: 8382148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice.
    Shook J; Kazmierski W; Hruby V; Burks T
    NIDA Res Monogr; 1988; 81():143-8. PubMed ID: 2900467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of acute and chronic morphine dependence in male and female mice.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A
    Pharmacol Biochem Behav; 2001 Sep; 70(1):149-56. PubMed ID: 11566152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.
    Bianchetti A; Guidice A; Nava F; Manara L
    Life Sci; 1986 Dec; 39(24):2297-303. PubMed ID: 3796195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.